The Bull Case For Liontown (ASX:LTR) Could Change Following New Canmax Offtake Deal And Spot Auction

• Earlier in December, Canmax Technologies announced a binding offtake agreement with Liontown for spodumene concentrate supply in 2027 and 2028, following Liontown’s successful first digital spot sales auction in November that highlighted strong demand for its product.
• Together, the long-term Canmax contract and the digital auction signal that Liontown is beginning to lock in future sales channels while testing more flexible ways to sell lithium into the market.
• We’ll now examine how this new Canmax offtake agreement could influence Liontown’s investment narrative around revenue visibility and earnings risk.

The latest GPUs need a type of rare earth metal called Terbium and there are only 35 companies in the world exploring or producing it. Find the list for free.

Liontown Investment Narrative Recap

To hold Liontown, you really need to believe in Kathleen Valley maturing into a reliable, competitively priced lithium producer despite current losses and sector volatility. The new Canmax offtake improves medium term revenue visibility, which supports that thesis, but it does not remove the near term risk that weaker lithium prices and higher operating costs could still pressure cash flow and keep earnings in the red.

Among Liontown’s recent announcements, the first digital spot sales auction in November matters most here because it complements the Canmax contract by showing there is active demand for its spodumene outside long term deals. Together, these sales channels speak directly to the key catalyst investors are watching: whether Liontown can ramp production, improve lithium recoveries and sell consistently enough to move closer to breakeven.

Yet while these agreements help with visibility, investors still need to be aware of how lower lithium prices combined with rising costs could...

Read the full narrative on Liontown (it's free!)

Liontown's narrative projects A$725.1 million revenue and A$62.7 million earnings by 2028. This requires 93.1% yearly revenue growth and an earnings increase of about A$111.8 million from A$-49.1 million today.

Uncover how Liontown's forecasts yield a A$1.07 fair value, a 26% downside to its current price.

Exploring Other Perspectives

Fifteen Simply Wall St Community valuations for Liontown range from A$0.15 to A$5.51 per share, underscoring how far apart individual views can be. When you set those opinions against the ongoing risk that lower lithium prices and higher operating costs could strain cash flow, it becomes even more important to weigh several different perspectives before deciding how Liontown might fit into your portfolio.

Explore 15 other fair value estimates on Liontown - why the stock might be worth over 3x more than the current price!

Build Your Own Liontown Narrative

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

• A great starting point for your Liontown research is our analysis highlighting 2 key rewards and 2 important warning signs that could impact your investment decision.
• Our free Liontown research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Liontown's overall financial health at a glance.

Seeking Other Investments?

Opportunities like this don't last. These are today's most promising picks. Check them out now:

• The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 24 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.
• This technology could replace computers: discover 28 stocks that are working to make quantum computing a reality.
• The end of cancer? These 29 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com